Published in J Neurol Neurosurg Psychiatry on February 17, 2016
Optic nerve sheath diameter threshold by ocular ultrasonography for detection of increased intracranial pressure in Korean adult patients with brain lesions. Medicine (Baltimore) (2016) 0.75
Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci (2016) 0.75
Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol (2017) 0.75
p53: key conductor of all anti-acne therapies. J Transl Med (2017) 0.75
Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults. J Neurol (2017) 0.75
Structural and functional features of central nervous system lymphatic vessels. Nature (2015) 8.73
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology (2013) 8.25
A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med (2012) 8.04
Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med (2005) 4.04
Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology (2003) 3.97
The vitamin A content and toxicity of bear and seal liver. Biochem J (1943) 3.75
Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol (1982) 3.50
INTRACRANIAL PRESSURE WITHOUT BRAIN TUMOR: DIAGNOSIS AND TREATMENT. Ann Surg (1937) 3.39
The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol (2014) 3.39
Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology (2002) 3.20
Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain (1991) 3.07
Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res (2008) 2.95
The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri) Ophthalmology (1998) 2.90
Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol (2007) 2.44
Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) (2008) 2.15
Meta-Analysis of CSF Diversion Procedures and Dural Venous Sinus Stenting in the Setting of Medically Refractory Idiopathic Intracranial Hypertension. AJNR Am J Neuroradiol (2015) 2.14
Fulminant idiopathic intracranial hypertension. Neurology (2007) 2.02
Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ (2010) 1.90
Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology (2012) 1.83
Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res (2004) 1.83
A comparison of idiopathic intracranial hypertension with and without papilledema. Headache (2009) 1.82
Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci (1993) 1.81
Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life. Neurology (2000) 1.80
Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology (2005) 1.51
Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol (2002) 1.50
Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma (2013) 1.46
Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension. Cephalalgia (2012) 1.44
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand (2007) 1.40
The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuroophthalmol (2014) 1.40
Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med (1974) 1.32
Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med (2005) 1.27
Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology (1998) 1.19
Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg (2010) 1.16
Role of secretion and bulk flow of brain interstitial fluid in brain volume regulation. Ann N Y Acad Sci (1988) 1.16
Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage. Transl Stroke Res (2012) 1.11
Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev (2010) 1.10
Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.09
Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology (2009) 1.07
Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol (2007) 1.07
Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol (2008) 1.06
The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther (1974) 1.05
A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol (2010) 1.02
Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology (1998) 1.02
Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci (2005) 1.02
CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study. Neurology (1992) 1.01
Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia (2004) 0.97
Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery (2005) 0.96
Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology (2011) 0.94
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. QJM (2003) 0.93
Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. J Neurol (2012) 0.91
Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci (2013) 0.91
A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol (2014) 0.91
The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol (2014) 0.90
Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia (2011) 0.89
Idiopathic intracranial hypertension and obesity. Horm Res Paediatr (2014) 0.89
Stenting and angioplasty for idiopathic intracranial hypertension: a case series with clinical, angiographic, ophthalmological, complication, and pressure reporting. J Neuroimaging (2015) 0.86
Cerebrospinal fluid estrone in pseudotumor cerebri: a change in cerebral steroid hormone metabolism? J Endocrinol Invest (1991) 0.86
Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? J Clin Endocrinol Metab (2010) 0.85
Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women. Curr Eye Res (2013) 0.84
Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry (2002) 0.84
Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results. Neurology (2015) 0.84
Headache arising from idiopathic changes in CSF pressure. Lancet Neurol (2015) 0.84
Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache. Curr Pain Headache Rep (2012) 0.84
The Incidence of Blindness Due to Idiopathic Intracranial Hypertension in the UK. Open Ophthalmol J (2013) 0.83
Brain Imaging in Idiopathic Intracranial Hypertension. J Neuroophthalmol (2015) 0.83
Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev (2015) 0.82
Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol (2015) 0.82
Idiopathic Intracranial Hypertension. A Systematic Analysis of Transverse Sinus Stenting. Interv Neurol (2013) 0.82
Cognitive function in idiopathic intracranial hypertension: a prospective case-control study. BMJ Open (2014) 0.82
Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol (2011) 0.81
The pseudotumor cerebri syndrome. Neurol Clin (2014) 0.79
Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology (1998) 0.78
Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion. Br J Ophthalmol (2014) 0.78
Medication overuse headache - An under-diagnosed problem in shunted idiopathic intracranial hypertension patients. Br J Neurosurg (2014) 0.78
Radioisotopic cisternography in benign intracranial hypertension of young obese women. A seven-case study and pathogenetic suggestions. Acta Neurol (Napoli) (1992) 0.77
Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci (2007) 0.77
Idiopathic intracranial hypertension: Clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia (2014) 0.77
Idiopathic Intracranial Hypertension in the Northwest of Northern Ireland: Epidemiology and Clinical Management. Neuroepidemiology (2015) 0.77
Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain (2015) 0.76